Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Two Considerations

So you honestly believe Alliacense is nearly done with their work and that they've notified all 450 possible infringers - that 450 companies are all that's out there infringing, and that are worthy of pursuing? Apparently that's the point I miss in this entire discussion.

Okay, if you are convinced that 450 is the entire population available to pursue, then there is no point in further discussion. And if this is the case, as you argue, then Alliacense doesn't need resources to increase and should in fact decrease resources because their work, at least on the technical research side, is virtually done. We should stop dedicating resources and reap the rewards available from 450. That's what you are saying, right? That's our disconnect, right?

So our little debate comes to an end....

Only problem is that IMO it is quite clear that the CURRENT (hopefully temporary) policy is to dedicate more resources as near term revenues from the MMP flow in. So it would appear that Alliacense has no clue that their work is winding down because they're nearly done - 450 is the max, there ain't no more.

You've obviously made an independent world-wide assessment of literally millions of companies, and 450 is the limit. Or perhaps you limited your research to just the top 100,000 candidate companies....but still, just the 450. And let's see, we've signed 70+, and are in some level of discussions with 225. Gosh, we ARE almost done. No point in looking further.... And all the companies we've signed were commonly known companies....

Okay....I give up.

SGE

Share
New Message
Please login to post a reply